Nature magazine addresses what scientists are discovering about the evolutionary battle COVID is undergoing inside our bodies. Throughout the course of a chronic SARS-CoV-2 infection, the virus might be evolving into dangerous new variants.
Read More »Topline results of a recent clinical trial showed that infliximab or abatacept “substantially improve[ed] clinical status and reduc[ed] deaths” in adult patients hospitalized with severe COVID-19. These drugs are often used to treat certain autoimmune diseases, including rheumatoid arthritis, psoriatic arthritis, Crohn’s disease, and ankylosing spondylitis.
Read More »A recent study was conducted by a team of researchers in Turkey looking at the composition and diversity of gut microbiota in children who had been diagnosed with multisystem inflammatory syndrome (MIS-C) and COVID-19.
Read More »In an article, published this week in Nature, researchers studied changes in brain structure following a SARS-CoV-2 infection. What they found suggests that COVID-19 may have the ability to damage the brain, potentially causing long-term deleterious effects.
Read More »